Imaging the area at risk in myocardial infarction with cardiovascular magnetic resonance

Erik B Schelbert, Timothy C Wong, Erik B Schelbert, Timothy C Wong

No abstract available

Keywords: Editorials; area at risk; magnetic resonance imaging; myocardial infarction; myocardial salvage.

Figures

Figure 1.
Figure 1.
Fewer than half of all MIs in randomly selected community‐dwelling older persons defined by CMR are clinically recognized.1 The prevalence is displayed according to diabetes status. CMR indicates cardiovascular magnetic resonance; MI, myocardial infarction.

References

    1. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012; 308:890-896.
    1. Schelbert EB, Rumsfeld JS, Krumholz HM, Canto JG, Magid DJ, Masoudi FA, Reid KJ, Spertus JA. Ischaemic symptoms, quality of care and mortality during myocardial infarction. Heart. 2008; 94:e2.
    1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100:1992-2002.
    1. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, Chen AY, Klein LW, Masoudi FA, McKay C, Hewitt K, Brindis RG, Peterson ED, Rumsfeld JS. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010; 56:254-263.
    1. Brieger D, Fox KA, Fitzgerald G, Eagle KA, Budaj A, Avezum A, Granger CB, Costa B, Anderson FA, Jr, Steg PG. Predicting freedom from clinical events in non‐ST‐elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009; 95:888-894.
    1. Dunlay SM, Weston SA, Killian JM, Bell MR, Jaffe AS, Roger VL. Thirty‐day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med. 2012; 157:11-18.
    1. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed‐enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double‐blinded, randomized trial. Circulation. 2008; 117:629-637.
    1. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE. Late gadolinium‐enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010; 3:743-752.
    1. Grieve SM, Mazhar J, Callaghan F, Kok CY, Tandy S, Bhindi R, Figtree GA. Automated quantification of myocardial salvage in a rat model of ischemia‐reperfusion injury using 3D high‐resolution MRI. J Am Heart Assoc. 2014; 3-e000956.10.1161/JAHA.114.001105
    1. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, Shah S, Greiser A, Kellman P, Arai AE. Myocardial edema as detected by pre‐contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012; 5:596-603.
    1. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal‐Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410:701-705.
    1. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RDCardiovascular Cell Therapy Research N. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012; 308:2380-2389.
    1. Surder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S, Turchetto L, Radrizzani M, Astori G, Schwitter J, Erne P, Zuber M, Auf der Maur C, Jamshidi P, Gaemperli O, Windecker S, Moschovitis A, Wahl A, Buhler I, Wyss C, Kozerke S, Landmesser U, Luscher TF, Corti R. Intracoronary injection of bone marrow‐derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation. 2013; 127:1968-1979.
    1. Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, Oh‐I D, Klein C, Berger F, Kuehne T. Assessment of diffuse myocardial fibrosis in rats using small‐animal Look‐Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging. 2011; 4:636-640.
    1. Arai AE, Leung S, Kellman P. Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction. Radiology. 2012; 265:23-32.
    1. Croisille P, Kim HW, Kim RJ. Controversies in cardiovascular MR imaging: T2‐weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology. 2012; 265:12-22.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever